EU regulators have approved the use of Pfizer vax, vaccination will begin on December 27, Health News, ET Health World

Amsterdam: European drug regulators approved the use of the Covid-19 vaccine developed by Pfizer Inc. of the United States and BioNTech, a German partner, on Monday, and the EU will begin vaccination within a week.

European Union countries such as Germany, France, Austria and Italy said they plan to start vaccination on December 27 to catch up with the United States and the United Kingdom, which started vaccination earlier this month.

After approval from the European Medicines Agency (EMA), the final step is approval by the European Commission, which is scheduled for the second half of Monday.

“Now we are acting swiftly, and we look forward to the European Commission’s decision by tonight,” Ursula von der Leyen said on Twitter.

Von der Leyen had already set a goal of starting vaccination from December 27th to 29th.

Preparations for the deployment of the vaccine are due to the identification of highly infectious new strains of coronavirus in the UK causing turmoil throughout the region, countries blocking travel relations with the UK and disrupting trade before Christmas holidays. ..

Emer Cooke, EMA’s Executive Director, said it would take a long time to inoculate 450 million people in 27 EU countries.

“Vaccines alone are not a silver bullet to return to normal life, but approval of this first vaccine is arguably a big step in the right direction, and 2021 could be brighter than 2020. It shows that there is, “she said. News briefing.

EMA officials said the vaccine is very likely to work against new variants of the coronavirus.

“We believe that vaccines are very likely to maintain protection against this new variant, even if they have not yet been fully confirmed,” said the person responsible for biological health threats and vaccine strategies. Marco Cavalelli says.

Vaccination drive

The pandemic has killed about 470,000 Europeans and is accelerating in the winter months, crushing the economy in the process. Many governments impose strict restrictions on households in an attempt to curb the second wave of infection and avoid the overwhelming health care system.

Student healthcare workers, retired doctors, pharmacists and soldiers are being drafted into an unprecedented scale European vaccination campaign.

The phased approach prioritizes front-line healthcare workers and seniors in long-term care facilities, and states that most national institutions will not reach the general public by the end of the first quarter of 2021 at the earliest. Means

The EU’s goal of 27 member states is to cover 70% of the 450 million people.

Swiss drug regulators approved the vaccine on Saturday for people over the age of 16.

The EMA began a rolling review of preliminary data for the Pfizer trial on October 6 to expedite the approval process, which normally takes at least 7 months.

The EMA grant, initially granted as a Conditional Marketing Approval (CMA), is valid for one year and can be renewed annually. After further checking the data, it can be converted to standard sales authorization. It is valid for 5 years, but can be renewed for an unlimited period of time.

This process took longer than the ultra-fast emergency approval given by the United Kingdom, the first Western country to approve the Covid-19 shot.

European drug test

This deployment will test Brussels’ ability to unite Europe under political pressure to speed up the process and curb a pandemic that killed more than 1.6 million people worldwide.

Last week, Germany, France, Italy, and five other European states agreed to coordinate the launch of vaccination campaigns.

The EU paid € 15.50 ($ 18.90) per dose to order 200 million Pfizer-BioNTech shots, enough to vaccinate 100 million people.

We have also purchased another $ 100 million and the delivery date is still under negotiation.

EMA officials denied political interference and defended the speed of the approval process.

Harald Enzmann, Chair of the EMA’s Committee for Medicinal Products for Human Use (CHMP), said: “The focus was only on science, and there was too much involvement of member states investigating science to allow political whitewashing and adaptation.

EU regulators have approved the use of Pfizer vax, vaccination will begin on December 27, Health News, ET Health World

Source link EU regulators have approved the use of Pfizer vax, vaccination will begin on December 27, Health News, ET Health World

Related Articles

Back to top button